Enhanced P2Y1 receptor expression in the brain after sensitisation with d-amphetamine

Psychopharmacology

Volumn 167, Issue 2, 2003, Pages 187-194

  Franke, Heike ^a   Kittner, Holger ^a   Grosche, Jens ^a   Illes, Peter ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Amphetamine; Astrocytes; Astrogliosis; ATP; Immunocytochemistry; Neurones; Nitric oxide synthase; P2 receptors; Sensitisation

Indexed keywords

ADENOSINE TRIPHOSPHATE; DEXAMPHETAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; PENICILLIN G; PURINE P2Y RECEPTOR; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; RETACILLIN; TUBULIN; CENTRAL STIMULANT AGENT; DRUG DERIVATIVE; PURINE P2 RECEPTOR; PURINE P2Y1 RECEPTOR; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL PHOSPHATE-6-AZOPHENYL-2',4'-DISULFONIC ACID;

ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL PROLIFERATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG SENSITIZATION; IMMUNOREACTIVITY; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; BRAIN; CONFOCAL MICROSCOPY; DRUG ANTAGONISM; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; METABOLISM; MOTOR ACTIVITY; NERVE CELL; WISTAR RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ASTROCYTES; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; FLUORESCENT ANTIBODY TECHNIQUE; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, CONFOCAL; MOTOR ACTIVITY; NEURONS; PYRIDOXAL PHOSPHATE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2; TUBULIN;

EID: 0038823522     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1386-6     Document Type: Article

References (58)

1. Abbracchio MP, Burnstock G (1994) Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64:445-475
2. Abbracchio MP, Brambilla R, Ceruti S, Cattabeni F (1999) Signalling mechanisms involved in P2Y receptor-mediated reactive astrogliosis. Prog Brain Res 120:333-342
3. Afanas'ev I, Ferger B, Kuschinsky K (2000) The associative type of sensitisation to d-amphetamine is expressed as an NO-dependent dramatic increase in extracellular dopamine in the nucleus accumbens. Naunyn-Schmiedeberg's Arch Pharmacol 362:232-237
4. Bolego C, Ceruti S, Brambilla R, Puglisi L, Cattabeni F, Burnstock G, Abbracchio MP (1997) Characterization of signalling pathways involved in ATP and basic fibroblast growth factor-induced astrogliosis. Br J Pharmacol 121:1692-1699
5. Bowyer JF, Clausing P, Gough B, Slikker W, Holson RR (1995) Nitric oxide regulation of methamphetamine-induced dopamine release in caudate/putamen. Brain Res 699:62-70
6. Braun N, Zhu Y, Krieglstein J, Culmsee C, Zimmermann H (1998) Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat. J Neurosci 18:4891-4900
7. Bredt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM, Snyder SH (1991) Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 7:615-624
8. Burnstock G (2001) Purine-mediated signalling in pain and visceral perception. Trends Pharmacol Sci 22:182-188
9. Communi D, Gonzalez NS, Detheux M, Brezillon S, Lannoy V, Parmentier M, Boeynaems JM (2001) Identification of a novel human ADP receptor coupled to G(i). J Biol Chem 276:41479-41485
10. Donaldson LF, Hanley MR, Villablanca AC (1997) Inducible receptors, Trends Pharmacol Sci 18:171-181
11. Eclancher F, Kehrli P, Labourdette G, Sensenbrenner M (1996) Basic fibroblast growth factor (bFGF) injection activates the glial reaction in the injured adult rat brain. Brain Res 737:201-214
12. Flores C, Steward J (2000) Changes in astrocytic basic fibroblast growth factor expression during and after prolonged exposure to escalating doses of amphetamine. Neuroscience 98:287-293
13. Flores C, Rodaros D, Stewart J (1998) Long-lasting induction of astrocytic basic fibroblast growth factor by repeated injections of amphetamine: blockade by concurrent treatment with a glutamate antagonist. J Neurosci 18:9547-9555
14. Flores C, Samaha AN, Stewart J (2000) Requirement of endogenous basic growth factor for sensitization to amphetamine. J Neurosci 20:1-5
15. Franke H (1995) Influence of chronic alcohol treatment on the GFAP-immunoreactivity in astrocytes of the hippocampus in rats. Acta Histochem 97:263-271
16. Franke H, Krügel U, Illes P (1999) P2 receptor-mediated proliferative effects on astrocytes in vivo. Glia 28:190-200
17. Franke H, Grosche J, Schädlich H, Krügel U, Allgaier C, Illes P (2001a) P2X receptor expression on astrocytes in the nucleus accumbens of rats. Neuroscience 108:421-429
18. Franke H, Krügel U, Schmidt R, Grosche J, Reichenbach A, Illes P (2001b) P2 receptor-types involved in astrogliosis in vivo. Br J Pharmacol 134:1180-1189
19. Gordon L (1986) Extracellular ATP: effects, sources and fate. Biochem J 233:309-319
20. Hess A, Desidero C, McAuliffe WG (1990) Acute neuropathological changes in the caudate nucleus caused by MPTP and methamphetamine: immunohistochemical studies. J Neurocytol 19:338-342
21. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden A, Julius D, Conley PB (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409:202-207
22. 1 receptor signaling in the nucleus accumbens. Synapse 45:159-170
23. Kálmán M, Hajós F (1989) Distribution of glial fibrillary acidic protein (GFAP)-immunoreactive astrocytes in the rat brain. Exp Brain Res 78:147-163
24. 1 dopamine receptor agonist when glutamate reuptake is inhibited. J Neurosci 21:1-6
25. Kittner H, Krügel U, Illes P (2001) The purinergic P2 receptor antagonist pyridoxalphosphate-6-azophenyl-2′,4′-disulphonic acid prevents both the acute locomotor effects of amphetamine and the behavioural sensitisation caused by repeated amphetamine injections in rats. Neuroscience 102:241-243
26. 1 receptor-mediated nitric oxide production. Neuropsychopharmacology (in press)
27. Krügel U, Kittner H, Illes P (1999) Adenosine 5′-triphosphate-induced dopamine release in the rat nucleus accumbens in vivo. Neurosci Lett 265:49-52
28. Krügel U, Kittner H, Franke H, Illes P (2001a) Stimulation of P2 receptors in the ventral tegmental area enhances dopaminergic mechanisms in vivo. Neuropharmacology 40:1084-1093
29. Krügel U, Kittner H, Illes P (2001b) Mechanisms of adenosine 5′-triphosphate-induced dopamine release in the rat nucleus accumbens in vivo. Synapse 39:222-232
30. 1 receptor stimulation facilitates dopamine release in the nucleus accumbens. Abstract 012.14, 3rd Forum of European Neuroscience, Paris, p 40, Abstract book
31. Lau JWS, Senok S, Stadlin A (2000) Methamphetamine-induced oxidative stress in cultured mouse astrocytes. Ann NY Acad Sci 914:146-56
32. Lenz G, Gootfried C, Luo Z, Avruch J, Rodnight R, Nie WJ, Kang Y, Neary JT (2000) P2Y purinoceptor subtypes recruit different Mek activators in astrocytes. Br J Pharmacol 129:927-936
33. Lin HC, Kang BH, Wong CS, Mao SP, Wan FJ (1999) Systemic administration of d-amphetamine induced a delayed production of nitric oxide in the striatum of rats. Neurosci Lett 276:141-144
34. Mao L, Wang JQ (2001) Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioural sensitization to repeated amphetamine administration. Synapse 41:230-240
35. Moore D, Chambers J, Waldvogel H, Faull R, Emson P (2000a) Regional and cellular distribution of the P2Y1 purinergic receptor in the human brain: striking neuronal localisation. J Comp Neurol 421:374-384
36. 1 purinergic receptor in Alzheimer's disease. NeuroReport 11:3799-3803
37. 1 purinergic receptor in neurons and glial cells of the central nervous system. Mol Brain Res 78:50-58
38. Neary JT, Zhu Q (1994) Signaling by ATP receptors in astrocytes. Neuroreport 5:1617-1620
39. Neary JT, Baker L, Jorgensen SL, Norenberg MD (1994a) Extracellular ATP induces stellation and increases glial fibrillary acidic protein content and DNA synthesis in primary astrocyte cultures. Acta Neuropathol 87:8-13
40. Neary JT, Whittemore SR, Zhu Q, Norenberg MD (1994b) Synergistic activation of DNA synthesis in astrocytes by fibroblast growth factors and extracellular ATP. J Neurochem 63:490-494
41. Neary JT, Rathbone MP, Cattabeni F, Abbracchio MP, Burnstock G (1996) Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci 19:13-18
42. Neary JT, McCarthy M, Cornell-Bel A, Kang Y (1999a) Trophic signaling pathways activated by purinergic receptors in rat and human astroglia. Prog Brain Res 120:323-332
43. Neary JT, Kang Y, Bu Y, Akong K, Peters CS (1999b) Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes: Involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the phosphatidyinositol-specific phospholipase C/calcium pathway. J Neurosci 19:4211-4220
44. O'Callaghan JP, Miller DB (1994) Neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 270:741-751
45. Pacchioni AM, Gionio G, Assis A, Cancela LM (2002) A single exposure to restraint stress induces behavioral and neurochemical sensitization to stimulating effects of amphetamine: involvement of NMDA receptors. Ann NY Acad Sci 965:233-246
46. Paxinos G, Watson C (1998) The rat brain stereotaxic coordinates, 4th edn. Academic Press, San Diego
47. Pintor J, Porras A, Mora F, Miras-Portugal MT (1995) Dopamine receptor blockade inhibits the amphetamine-induced release of diadenosine polyphosphates, diadenosine tetraphosphate and diadenosine pentaphosphate, from neostriatum of the conscious rat. J Neurochem 64:670-676
48. Pu C, Vorhees VC (1993) Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum. Dev Brain Res 72:325-328
49. Pu C, Vorhees CV (1995) Protective effects of MK-801 on methamphetamine-induced depletion of dopaminergic and serotonergic terminals and striatal astrocytic response: an immunocytochemical study. Synapse 19:97-104
50. Pu C, Fisher JE, Cappon GD, Vorhees CV (1994) The effects of amonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum. Brain Res 649:217-224
51. Ralevic V, Burnstock G (1998) Receptor for purines and pyrimidines. Pharmacol Rev 50:413-492
52. 2-purinergic/pyrimidinergic receptor. J Neurochem 64:61-68
53. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18:247-291
54. Robinson TE, Kolb B (1997) Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 17:8491-8497
55. 1 receptor stimulate mitogen-activated protein kinase and induce apoptosis. J Biol Chem 276:16379-16390
56. Stadlin A, Lau JWS, Szeto YK (1998) A selective regional response of cultured astrocytes to methamphetamine. Ann NY Acad Sci 844:108-121
57. Vincent SR (1994) Nitric oxide: a radical neurotransmitter in the central nervous system. Prog Neurobiol 42:129-160
58. Von Kügelgen I, Wetter A (2000) Molecular pharmacology of P2Y-receptors. Naunyn-Schmiedeberg's Arch Pharmacol 362:310-323